Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PF-06425090 in healthy adults
NCT02117570Phase 2Completed
- Sponsor
- Pfizer
- Start
- Jul 2014
- Primary completion
- Dec 2015
- Modality
- Vaccines & Immunotherapeutics, mRNA Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of Clostridium difficile vaccine in Clostridium difficile infection (CDI), sponsored by Pfizer. Started Jul 2014; status: completed.
02
Drugs
Clostridium difficile vaccine
03
Conditions
Clostridium difficile infection (CDI)
Beyond the preview
Go deeper on NCT02117570.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02117570.